SUNPHARMA.NSSUNPHARMA.NSNSE
Loading
Year-over-year earnings per share growth rate
5Y CAGR
+43.5%/yr
Long-term compound
Percentile
P67
Within normal range
vs 5Y Ago
6.1x
Strong expansion
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 8.00% |
| Q3 2025 | 36.84% |
| Q2 2025 | 5.56% |
| Q1 2025 | -25.62% |
| Q4 2024 | -4.72% |
| Q3 2024 | 7.45% |
| Q2 2024 | 6.49% |
| Q1 2024 | 5.51% |
| Q4 2023 | 6.26% |
| Q3 2023 | 17.44% |
| Q2 2023 | 1.93% |
| Q1 2023 | -8.42% |
| Q4 2022 | -4.24% |
| Q3 2022 | 9.65% |
| Q2 2022 | 190.62% |
| Q1 2022 | -210.35% |
| Q4 2021 | 1.18% |
| Q3 2021 | 41.67% |
| Q2 2021 | 60.86% |
| Q1 2021 | -51.56% |
| Q4 2020 | 1.32% |
| Q3 2020 | 210.14% |
| Q2 2020 | -513.17% |
| Q1 2020 | -56.17% |
| Q4 2019 | -14.00% |
| Q3 2019 | -23.36% |
| Q2 2019 | 118.11% |
| Q1 2019 | -48.84% |
| Q4 2018 | 669.23% |
| Q3 2018 | -120.63% |
| Q2 2018 | -19.82% |
| Q1 2018 | 310.45% |
| Q4 2017 | -64.74% |
| Q3 2017 | 311.11% |
| Q2 2017 | -134.62% |
| Q1 2017 | -14.75% |
| Q4 2016 | -34.41% |
| Q3 2016 | 9.41% |
| Q2 2016 | 44.07% |
| Q1 2016 | -7.81% |